Skip to main content Skip to section navigation Skip to footer
Stock Information
chevron_left Back to CastleBiosciences.com
Castle Biosciences, Inc. IR Home
  • Overview
  • News & Events keyboard_arrow_down
    • Press Releases
    • IR Events
    • Presentations
    • In The Media
    • Annual Meeting
    • Email Alerts
  • Company Info keyboard_arrow_down
    • Company Profile
    • Executive Team
    • Annual Reports & Proxy
    • Contacts
    • FAQ
  • Financial Info keyboard_arrow_down
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data keyboard_arrow_down
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings keyboard_arrow_down
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance keyboard_arrow_down
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Corporate Responsibility
  • Resources keyboard_arrow_down
    • Scientific Evidence
  • Stock Information
  • chevron_leftBack to CastleBiosciences.com

In The Media

News & Events

  • Press Releases
  • IR Events
  • Presentations
  • In The Media
  • Annual Meeting
  • Email Alerts
Apr 4, 2025
Houston Business Journal: Here Are the Fastest-Growing Middle-Market Companies in Houston
Apr 4, 2025
Cancer Network: DecisionDx-Melanoma Test Accurately Identifies Low-Risk SLN Positivity
Apr 3, 2025
The Dermatology Digest: New Research Confirms Castle Biosciences’ DecisionDx-Melanoma Test’s Ability to ID Patients Who Can Safely Forgo SLNB
Apr 3, 2025
Cancer Therapy Advisor: 40-GEP Test Can Improve Risk Stratification in CSCC
Apr 2, 2025
Gastroenterology & Endoscopy News: Studies Support Risk Scoring Test For Barrett’s Esophagus Progression
Apr 1, 2025
All Fore Guts! An American Foregut Society Podcast: Not Just Heartburn, It Could Be Cancer: Esophageal Cancer Awareness Month
Mar 21, 2025
Drug Target Review: Beyond the Lab Report: Artificial Intelligence
Mar 20, 2025
USA Today Top Workplaces USA: Castle Biosciences Ranks 30th Among Companies with 500-999 Employees
Mar 19, 2025
Dermatology Times: Multidisciplinary Approaches to Advanced BCC and CSCC
Feb 28, 2025
GenomeWeb: Castle Biosciences Q4 Revenues up 31 Percent
rss_feed RSS
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • …
  • Page 26
  • Next Pagearrow_forward
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2026 Castle Biosciences, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.